MHRA receives further ADR reports with varenicline

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1664, 2008-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MHRA receives further ADR reports with varenicline

By  

Reactions Weekly, Vol. 1, Iss. 1228, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Finland's regulatory agency receives record number of ADR reports

By  

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

According to the MHRA, a total of 5 fatal ADR reports in patients receiving rimonabant [Acomplia] have been received in the UK

By  

Reactions Weekly, Vol. 1, Iss. 1206, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Varenicline: suicidal behaviour/thoughts reported to MHRA

By  

Inpharma, Vol. 1, Iss. 1647, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

ADR reports show gender differences

By  

Reactions Weekly, Vol. 1, Iss. 1387, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite